Statistics for Evaluación de la persistencia, tasa de retención y pauta de prescripción de infliximab original e infliximab CT-P13 en pacientes naive biológicos con colitis ulcerosa
Total visits
| views | |
|---|---|
| Evaluación de la persistencia, tasa de retención y pauta de prescripción de infliximab original e infliximab CT-P13 en pacientes naive biológicos con colitis ulcerosa | 443 |
Total visits per month
| views | |
|---|---|
| June 2024 | 13 |
| July 2024 | 8 |
| August 2024 | 14 |
| September 2024 | 10 |
| October 2024 | 2 |
| November 2024 | 1 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| Evaluacion_Valcuende_FH_2022.pdf | 82 |
Top country views
| views | |
|---|---|
| Ireland | 44 |
| Russia | 25 |
| United States | 21 |
| China | 4 |
| Spain | 4 |
| Australia | 3 |
| United Kingdom | 3 |
| Venezuela | 2 |
| Argentina | 1 |
| Belgium | 1 |
| Singapore | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Dublin | 44 |
| Moscow | 10 |
| Noginsk | 6 |
| Khimki | 5 |
| Balashikha | 2 |
| Krasnogorsk | 2 |
| Valencia | 2 |
| Auburn | 1 |
| Beijing | 1 |
| Boardman | 1 |
| Madrid | 1 |
| Melbourne | 1 |
| Qingdao | 1 |
| San Mateo | 1 |
| Xiamen | 1 |